ProNAi Therapeutics, Inc. is dedicated to developing and commercializing a new class of therapies that target DNA to treat patients with cancer and other diseases.

ProNAi Therapeutics, Inc. is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi®, to advance a new generation of therapies for patients with cancer and other diseases.

ProNAi is focused on the further development of its promising DNAi® pipeline, on the strength of compelling clinical and preclinical results to date.

   

 

 

 

 

 

 

Copyright © 2005- ProNAi Therapeutics, Inc. All Rights Reserved.